We are live on ! Find out more
ASXC

Asensus Surgical, Inc.
ASXC

Delisted

ASXC was delisted on the 21st of August, 2024.

Back to rankings

1 hedge funds and large institutions have $3.65K invested in Asensus Surgical, Inc. in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 62 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% less funds holding

Funds holding: 64 → 1 (-63)

100% less capital invested

Capital invested by funds: $13.2M → $3.65K (-$13.2M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 62

Holders
1
Holders Change
-63
Holders Change %
-98.44%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
62
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BCM
Beryl Capital Management
California
-$4.83M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$3.86M
3
BlackRock
BlackRock
New York
-$1.15M
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$832K
5
MCM
Masters Capital Management
Georgia
-$666K
Name Holding Trade Value Shares
Change 		Change in
Stake
Dimensional Fund Advisors
26
Dimensional Fund Advisors
Texas
– -$8.07K -24,244 Closed
Bank of New York Mellon
27
Bank of New York Mellon
New York
– -$8.06K -24,195 Closed
JC
28
JBF Capital
Colorado
– -$7.66K -23,016 Closed
BBA
29
Baader Bank Aktiengesellschaft
Germany
– -$6.2K -22,901 Closed
ACI
30
Alpha Cubed Investments
California
– -$5K -15,000 Closed
RJFSA
31
Raymond James Financial Services Advisors
Florida
– -$4.69K -14,072 Closed
APP
32
Avantax Planning Partners
Iowa
– -$4.31K -12,936 Closed
Cetera Investment Advisers
33
Cetera Investment Advisers
Illinois
– -$4.12K -12,379 Closed
Commonwealth Equity Services
34
Commonwealth Equity Services
Massachusetts
– -$4K -12,176 Closed
CL
35
Choreo LLC
Illinois
– -$3.57K -10,661 Closed
Group One Trading
36
Group One Trading
Illinois
– -$3.33K -10,013 Closed
CHAM
37
Clear Harbor Asset Management
Connecticut
– -$3.33K -10,000 Closed
CFD
38
Creative Financial Designs
Indiana
– -$3.33K -10,000 Closed
LFAS
39
Level Four Advisory Services
Texas
– -$3.33K -10,000 Closed
LWM
40
LJI Wealth Management
Indiana
– -$3.33K -10,000 Closed
Fidelity Investments
41
Fidelity Investments
Massachusetts
– -$1.6K -4,814 Closed
TWC
42
TD Waterhouse Canada
Ontario, Canada
– -$1.33K -4,000 Closed
CIBC Private Wealth Group
43
CIBC Private Wealth Group
Georgia
– -$1.11K -3,300 Closed
NA
44
NewEdge Advisors
Louisiana
– -$666 -2,000 Closed
ADL
45
Asset Dedication LLC
California
– -$368 -1,105 Closed
Comerica Bank
46
Comerica Bank
Texas
– -$359 -1,077 Closed
SPIA
47
Steward Partners Investment Advisory
New York
– -$167 -500 Closed
AWM
48
Activest Wealth Management
Florida
– -$154 -462 Closed
FDCDDQ
49
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$121 -364 Closed
S
50
SignatureFD
Georgia
– -$101 -302 Closed
1
2
3

ASXC Hedge Fund Activity: Q3 2024 in Review

1 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Asensus Surgical, Inc. (ASXC) for Q3 2024, worth a combined $3.65K — down 100% from $13.2M a quarter earlier.

Sellers outnumbered buyers: 62 funds closed out of ASXC and 0 opened new positions — a net loss of 62 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Beryl Capital Management, exiting entirely with an estimated $4.83M sold.

  • 1 institutional investor held Asensus Surgical, Inc. (ASXC) as of Q3 2024, down from 64 in Q2 2024.
  • Funds reported $3.65K of Asensus Surgical, Inc. stock for Q3 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Asensus Surgical, Inc. positions in Q3 2024 and 62 closed out, a net change of -62 holders.
  • The largest Asensus Surgical, Inc. seller in Q3 2024 was Beryl Capital Management, an estimated $4.83M sold.

Based on aggregated 13F filings for Q3 2024.